U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Fig 2

Fig 2. From: Renal Function After Ifosfamide, Carboplatin, and Etoposide (ICE) Chemotherapy, Nephrectomy, and Radiotherapy in Children With Wilms Tumour.

Bland-Altman plot to assess agreement between GFR and estimated creatinine clearance (n = 35 pairs). The solid line represents the bias of the difference between pairs (17.8 ml/min per 1.73 m2) and the dashed lines represent the 95% confidence interval.

Najat C. Daw, et al. Eur J Cancer. ;45(1):99-106.
2.
Fig 3

Fig 3. From: Renal Function After Ifosfamide, Carboplatin, and Etoposide (ICE) Chemotherapy, Nephrectomy, and Radiotherapy in Children With Wilms Tumour.

Renal tubular function was longitudinally assessed by measuring urinary magnesium excretion (a), renal tubular threshold for phosphate (b), and urinary β2-microglobulin (c) in patients with Wilms tumour treated with ICE. Shaded areas (a, b) represent the normal range.

Najat C. Daw, et al. Eur J Cancer. ;45(1):99-106.
3.
Fig 1

Fig 1. Therapy schema. From: Renal Function After Ifosfamide, Carboplatin, and Etoposide (ICE) Chemotherapy, Nephrectomy, and Radiotherapy in Children With Wilms Tumour.

V=vincristine 1.5 mg/m2 (maximum dose, 2 mg); D=dactinomycin 0.6 mg/m2 (maximum dose, 2 mg); A=doxorubicin (Adriamycin) 25 mg/m2; ICE chemotherapy: C=carboplatin, dosage based on GFR to target an AUC of 6 mg/ml × min on day 1; E=etoposide 100 mg/m2 per day on days 2–4; I=ifosfamide 2 g/m2 per day on days 2–4.

Najat C. Daw, et al. Eur J Cancer. ;45(1):99-106.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center